Kevin Bitterman - Director at Akero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AKRO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kevin Bitterman since 12/22/2023

Holdings reported by Kevin Bitterman for Akero Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 13K Jun 1, 2021 Direct Common Stock
Common Stock 0 $0.62 Jun 1, 2021 Indirect

Transactions reported by Kevin Bitterman for Akero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.